Diabetes Mellitus - PowerPoint PPT Presentation

1 / 56
About This Presentation
Title:

Diabetes Mellitus

Description:

Orthostatic hypotension elastic stockings. Infections ... Physical signs include black eschar on nasal mucosa or hard palate due to ischemia ... – PowerPoint PPT presentation

Number of Views:120
Avg rating:3.0/5.0
Slides: 57
Provided by: billie7
Category:

less

Transcript and Presenter's Notes

Title: Diabetes Mellitus


1
Diabetes Mellitus
  • Jane DisaSmith, D.O.
  • Dec. 13, 2005
  • Slides by Billie Hall, D.O.

2
Classification
  • Diabetes can be grouped into 4 major categories
  • Type 1 (IDDM) deficiency of insulin secretion
  • Type 2 (NIDDM) resistance to action of insulin
    by target organs and tissues
  • Secondary causes such as drugs (steroids),
    genetics (down syndrome)
  • Gestational DM

3
Epidemiology
  • Estimated that 100 million people worldwide have
    DM 85-90 are type II
  • In the U.S. aprox 5.9 million do not know they
    have diabetes
  • From 1990-98, prevalence of DM rose 33, in part
    to the increase in population over 65, but also
    related to epidemic levels obesity

4
Risk Factors
  • Type I
  • Genetic predisposition if father has type I (3x
    more likely than if mom)
  • Dietary factors such as exposure to cows milk
    proteins, bovine serum albumin at age less than 3
    months
  • Viral infections such as Coxsackie B, CMV and
    mumps

5
Risk Factors
  • Type II (table 212-2)
  • Hypertension (140/90)
  • Dyslipidemia (HDL
    250)
  • Diet (high fat, starch, low fiber)
  • Sedentary lifestyle
  • Obesity (BMI 25kg/m2

6
Pathophysiology
  • Type I destruction of insulin-producing
    pancreatic beta cells and absolute insulin
    deficiency.
  • Type II development of insulin resistance and
    increased insulin production

7
Pathophysiology
  • Organs and tissues most affected by DM retina,
    kidneys and nerves all readily take up glucose.
  • This leads to intracellular accumulation of
    metabolic end products (sorbitol)

8
Pathophysiology
  • Sorbitol competitively inhibits myo-inositol
    formation which causes a decrease in the uptake
    of phosphoinositides into cell membranes, leading
    in turn to a decrease in NaKATPase activity
  • Ultimate effect slowed nerve conduction leading
    to neuropathy, retinopathy and nephropathy

9
Clinical features
  • Type I frequently presents as DKA, associated
    with an infection or other stressor in children
    and young adults
  • Type II can be present for years before onset of
    clinical symptoms and sometimes is dx only with
    initial presentation of microvascular or
    infection complication of the disease

10
Clinical features
  • Classic DM signs and symptoms may include
    polyuria, polydipsia, fatigue polyphagia,
    unexplained weight loss, poor wound healing,
    blurred vision, and certain infections such as
    candidal vaginitis and balanitis, and recurrent
    UTIs

11
Clinical features
  • Symptoms of poor glucose control include visual
    changes, neurologic symptoms (such as numbness,
    dizziness and weakness), GI symptoms, GU symptoms
    (overflow incontinence, changes in amt of urine,
    sexual dysfunction)

12
Physical Exam
  • When a diabetic patient presents to ER, PE should
    be tailored to their complaint. But it should
    also include BP measurement, fundoscopy, good
    cardio exam (bruits in abdomen and carotids),
    extremity exam (esp. feet), and good neuro exam
    (looking for neuropathy)

13
Optic Exam
  • TESTING OF VISUAL ACUITY MAY REVEAL PATIENTS
    INABILITY TO MEASURE A SELF-ADMINISTERED INSULIN
    DOSE

14
Diagnosis
  • Diagnosis of DM can be established in 3 ways, 2
    of which may be feasible in the ER. (Table
    212-4)
  • 1. Symptoms of DM plus casual plasma glucose
    level 200mg/dL (casual defined as any time of
    day)
  • 2. FPG 126 mg/dL (fasting at least 8 hrs)
  • 3. Oral Glucose Tolerance Test

15
OGTT
  • 75 grams of glucose dissolved in water, which
    patient drinks.
  • 2 hours later, blood glucose level of 200 mg/dL
    or greater is a positive test

16
Acute Hyperglycemia
  • Defined as BG 300
  • Can represent metabolic decompensation
  • If chronic, can represent high risk for
    developing macro and microvascular complications

17
Clinical Features
  • HP should focus on finding source of
    hyperglycemia, such as any medications patient is
    on that could contribute (steroids)
  • Look for source of infectious process (pneumonia,
    UTI)
  • ACS or CNS assault can cause hyperglycemia

18
Clinical Features
  • Also look for changes or non-compliance with
    insulin or oral hypoglycemic therapy
  • Younger adults may present with polyuria or
    polydipsia as symptoms, whereas older diabetics
    may present severely volume depleted with acute
    mental status changes

19
Clinical Features
  • Lab tests
  • Electrolytes, BUN/Cr, ABG (though Tintinalli
    feels this is not always necessary)
  • Blood glucose measurements every 1-2 hours

20
Therapy
  • Volume repletion
  • IV regular Insulin
  • Correction of electrolyte imbalance
  • Correction of any causes of the hyperglycemia
    (infections)

21
Therapy
  • Most significant electrolyte disorder is
    hypokalemia.
  • Total body deficit secondary to significant
    extracellular volume loss
  • Initial metabolic acidosis, which can elevate
    potassium levels, can mask true potassium deficits

22
Hypokalemia
  • Potassium replacement should be a priority if
    level is at or below 5.5 mEq/L, assuming normal
    renal function
  • Even with compromised renal function, levels at
    3.3 mEq/L represent a severe deficit and need
    supplementation to prevent lethal dysrhythmias

23
Long-term Therapy
  • For Type I, insulin therapy is key. Motivated
    patients can monitor their blood glucose levels
    and can self administer insulin to keep levels
    normal or as near normal as possible.
  • Can also rely on an insulin pump that delivers a
    basal rate, with pre-programmed or patient set
    boluses around meals.

24
Long-term Therapy
  • Type II diabetics use a staged approach.
  • Stage 1 diet control and weight mgt
  • Stage 2 oral hypoglycemic meds
  • Stage 3 addition of insulin if failing oral
    agent therapy

25
Long-term Therapy
  • Generally medication adjustment is best left to
    the primary care doc as dosage changes require
    close monitoring
  • But if not readily available, adjustment of
    insulin units should not be more than 10
    increase or decrease in a single day
  • Oral med dosages should not be more than 20
    increase or decrease

26
Complications
  • Cardiovascular
  • Leading cause of DM deaths, accounting for 40 in
    men and 32 in women
  • Diabetics have six times the risk of MI as
    opposed to non-diabetics

27
Cardiovascular
  • Contributing Factors
  • Increased incidence of atherosclerosis on
    coronary vessels
  • Microvascular disease, contributing to silent
    MIs (painless MIs)

28
Cardiovascular
  • Therapy to reduce CV events include aggressive BP
    control to 130/80 or less
  • Reduction of serum cholesterol to less than
    200mg/dL
  • Anti-platelet therapy with Aspirin or Plavix if
    ASA allergy
  • ACEIs to reduce nephropathy and CV events

29
Retinopathy
  • Diabetic retinopathy is leading cause of cases of
    new blindness in ages 25 to 74 in US
  • Glaucoma and cataracts more common in diabetics

30
Retinopathy
  • In the ED, any history of vision changes,
    blurriness should arouse suspicion for
    retinopathy
  • Retinal exam might show microaneurysms, exudates,
    and vascular proliferation

31
Retinopathy
  • Red and/or painful eye with a HA, OR unexplained
    HA in a diabetic should warrant an intraocular
    pressure measurement
  • All of these should include prompt referral to an
    ophthalmologist

32
Nephropathy
  • One of the leading causes of end stage renal
    disease is DM nephropathy
  • Aprox 43 of new renal failure cases each year
    are DM nephropathy

33
Nephropathy
  • Hyperglycemia leads to glomerular HTN and
    hyperfiltration, which in turn leads to
    deposition of protein in mesangium
  • These protein deposits cause sclerosis of the
    glomerulus and then renal failure

34
Nephropathy
  • Most useful clinical marker is microalbuminuria
  • Excretion of 30mg/day are still at high risk for
    developing nephropathy
  • Microalbuminuria has also been shown to be
    associated with increased risk of coronary
    ischemic events

35
Nephropathy
  • ACEIs have been shown to delay onset and
    progression of DM nephropathy
  • Overall prevention of DM nephropathy involves
    glycemic control, tx of htn, restriction of
    dietary protein and avoidance of nephrotoxic
    drugs/dyes

36
Neuropathy
  • Divided into peripheral and autonomic
  • Peripheral involves loss of both myelinated and
    unmyelinated fibers
  • Usually bilateral, can result in stocking or
    glove like distributions of numbness to a
    constant burning sensation

37
Neuropathy
  • Exam may show decrease or loss of vibratory sense
    and DTRs
  • Loss of these put the patient at high risk of
    foot ulcers

38
Neuropathy
  • Drugs used to tx include TCAs (amitriptyline) as
    well as neurontin and phenytoin
  • Avoid narcotics (abuse potential) and NSAIDs for
    possible nephrotoxic effects

39
Neuropathy
  • Autonomic neuropathy represent GI reflux,
    gastroparesis, neurogenic bladder, sexual
    dysfunction, and orthostatic hypertension

40
Neuropathy
  • Treatments
  • GERD H2 blockers and PPIs
  • Gastroparesis Reglan
  • Constipation Fiber
  • Neurogenic bladder bethanechol
  • Erectile dysfunction sildenafil (avoid in pts
    taking nitrates)
  • Orthostatic hypotension elastic stockings

41
Infections
  • Diabetics have impaired PMN leukocytes, such as
    migration problems, phagocytosis and
    intracellular killing all leading to intrinsic
    decrease in immunity
  • Have a low threshold when deciding when to start
    IV Abx or when to admit a diabetic patient to the
    hospital for Abx therapy

42
Infections
  • Fever without a clear source is a good enough
    reason to admit a diabetic patient to the hospital

43
Weird Infections
  • Rhinocerbral Mucormycosis
  • Fungal infection of the nasal and paranasal
    sinuses
  • 70 occur in patients in DKA
  • Patient presents with periorbital or perinasal
    pain, blood tinged nasal discharge, unilateral
    HA, decreased vision

44
Rhinocerebral mucorm
  • Physical signs include black eschar on nasal
    mucosa or hard palate due to ischemia
  • Seizures can occur as well as brain abscesses
  • Mortality is high - 50, ENT consult is a must
    for debridement of necrotic tissue
  • Drug of choice? Amphotericin B

45
Malignant Otitis Externa
  • Present with unilateral otalgia, decreased
    hearing, purulent discharge, fever
  • Exam finds a tender inflamed external auditory
    canal
  • Can progress to the mastoid, temporal bone or
    base of skull and meningitis

46
MOE
  • Frequently due to Pseudomonas aeruginosa
  • Abx for 4-6 weeks needed
  • Cipro, or 3rd gen cephs and an antipseudomonal
    pen - ticarcillin

47
Cholecystitis
  • Diabetics have higher incidence of gangrenous
    gallbladder that is more likely to perforate
  • Unexplained fever, with or without abd pain
    should be evaluated with U/S for for stones
  • Frequently due to Clostridium

48
Foot ulcers
  • Account for nearly 60 of Lower Extremity
    amputations in US
  • Neuropathy predisposes the foot to ulceration and
    infection
  • A through exam of a diabetics feet should be
    performed during ER visits, even with unrelated
    complaints

49
Foot Ulcers
  • Defined as non limb threatening, limb threatening
    and life threatening
  • Non limb threatening defined as small (aprox 2
    cm) of cellulitis or imflammation and does not
    involve deep structures or bone

50
Foot Ulcers
  • Limb threatening is more than 2 cm of cellulitis
    with assoc ascending lymphangitis, deep
    ulcerations or abcess, large area of necrotic
    tissue, involvement of bone, gangrene and absence
    of palpable pulses

51
Foot ulcers
  • Life threatening includes signs of sepsis such as
    fever, leukocytosis, hypotension, tachycardia,
    altered mental status and metabolic abnormalities
    such as DKA

52
Foot Ulcers
  • Treatment depends on severity
  • Non limb threatening (PO) Cephalexin,
    Clindamycin, Dicloxacillin, Augmentin
  • Limb threatening (IV) Amp-sulbactam, Tic-clav,
    Cipro
  • Life threatening Imipenem-cilastatin,
    Amp-sulbactam, Vanco

53
Admissions to Hospital
  • Table 212-9 is a good lengthy table of
    disposition/admission guidelines

54
Questions
  • 1. Type I diabetes is characterized by insulin
    resistance and an increase of insulin production
    T or F
  • 2. If a patient is in DKA, and their initial BMP
    potassium is normal, you dont have to worry
    about supplementing K. T or F

55
Questions
  • 3. The organs and tissues most affected by
    diabetes nerves, kidneys and retina all
    readily take up glucose, hence causing all the
    problems. T or F
  • 4. Glaucoma and cataracts are less common in
    diabetics than in the regular population T or F

56
Questions
  • 5. If a diabetic presents to the ER with
    non-foot related complaints, then you dont have
    to worry about doing a foot exam. T or F
  • 1. F, that is type II
  • 2. F, they are still at a total body deficit
  • 3. T
  • 4. F
  • 5. F, You must still do a thorough exam
Write a Comment
User Comments (0)
About PowerShow.com